WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

23andMe founder buys back genetic testing company in second auction

Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals

sabato 14 giugno 2025 New tab

Other newsrooms on this story

· 4 sources

Full timeline →

cnbc.com·Jun 13, 2025 · 1 anni fa
Anne Wojcicki to buy back 23andMe and its data for $305 million
huffpost.com·Jun 16, 2025 · 1 anni fa
23andMe's Founder Wins Bid For Bankrupt DNA Testing Firm
theguardian.com·Jun 16, 2025 · 1 anni fa
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
techcrunch.com·Jun 14, 2025 · 1 anni fa
Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe | TechCrunch

Related reading

Anne Wojcicki to buy back 23andMe and its data for $305 million

Anne Wojcicki to buy back 23andMe and its data for $305 million

cnbc.com·1 anni fa

Abbott strikes $23bn deal for Cologuard cancer test maker Exact Sciences

Transaction continues a frenzy of M&A activity this year in the healthcare sector

ft.com·7 mesi fa

Eli Lilly close to buying gene-editing biotech Verve Therapeutics

Drugmaker nears $1.3bn deal in search for experimental medicines

ft.com·1 anni fa

23andMe's Founder Wins Bid For Bankrupt DNA Testing Firm

The nonprofit she controls said it would uphold 23andMe's existing privacy policies.

huffpost.com·1 anni fa

theguardian.com

23andMe’s founder wins bid to regain control of bankrupt DNA testing firm

Anne Wojcicki made $305m bid for firm, which has lost customers since declaring bankruptcy, with backing of Fortune 500 company

theguardian.com·1 anni fa

Thermo Fisher aims to sell parts of its diagnostics business for $4bn

Deal would mark latest move by a life sciences group to jettison lower-growth assets

ft.com·1 anni fa